Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BPK-29 is a ligand of the orphan nuclear receptor DAX1, also known as NR0B1.1 It covalently binds to DAX1 at Cys274 and inhibits the protein-protein interaction between DAX1 and SNW1 (IC50 = ~10-20 µM) and between DAX1 and RBM45 at 30 µM. BPK-29 (5 µM) inhibits the anchorage-independent growth of KEAP1-mutant H460 non-small cell lung cancer (NSCLC) cells.
WARNING This product is not for human or veterinary use.
1. Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer. Cell 171(3), 696-709 (2017).